PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
批准号:
3874383
负责人:
Y POMMIER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Bloom syndrome DNA binding protein DNA gyrase DNA repair DNA topoisomerases anthracyclines antineoplastics biological signal transduction calcium camptothecin doxorubicin drug metabolism drug resistance enzyme complex enzyme inhibitors enzyme mechanism etoposide gene mutation glycoproteins molecular oncology neoplasm /cancer chemotherapy pleiotropism podophyllin protein kinase C vincristine
中文摘要
DNA拓扑异构酶是癌症化疗的主要靶点。拓扑异构
拓扑异构酶I集中在核仁中,拓扑异构酶II是拓扑异构酶I的主要成分。
间期核和中期染色体的核支架
脚手架拓扑异构酶II活性是染色体分离所必需的
在有丝分裂期间,这两种酶都参与DNA代谢。
喜树碱抑制拓扑异构酶I和DNA嵌入剂(安吖啶,
蒽环类)和去甲基表鬼臼毒素(VP-16和VM-26)抑制
拓扑异构酶Ⅱ酶抑制是由酶联DNA断裂引起的,
这被认为是药物的初始细胞毒性损伤。
然而,在药物去除后,断裂迅速逆转。这促使我们
确定拓扑异构酶连接的DNA诱导的细胞毒性病变
休息.我们已经发现,拓扑异构酶I-DNA复合物诱导
喜树碱可能通过与细胞因子相互作用而杀死快速增殖的细胞。
DNA复制复合物。我们还确定,
拓扑异构酶介导的DNA断裂在已经被
缺乏钙我们已经证实了我们先前的发现,
通过暴露于阿霉素选择的多效性抗性细胞系是
对其他拓扑异构酶II抑制剂具有交叉耐药性,
增加的P-糖蛋白和修饰的拓扑异构酶II。另外我们
已经发现,选择的对长春新碱耐药的细胞增加了,
不含耐药拓扑异构酶II的P-糖蛋白。最后我们发现
两种形式的DNA拓扑异构酶I受信号调节的证据
包括蛋白激酶C的转导途径。
英文摘要
DNA topoisomerases are major targets for cancer chemotherapy. Topoisomerase
I is concentrated in nucleoli and topoisomerase II is a major component of
the nuclear scaffold for interphase nuclei and of the metaphase chromosome
scaffold. Topoisomerase II activity is required for chromosome segregation
during mitosis and both enzymes are involved in DNA metabolism.
Camptothecin inhibits topoisomerase I, and DNA intercalators (amsacrine,
anthracyclines) and demethylepipodophyllotoxins (VP-16 & VM-26) inhibit
topoisomerase II. Enzyme inhibition results from enzyme-linked DNA breaks,
which are believed to be the initial cytotoxic lesions of the drugs.
However, the breaks reverse quickly upon drug removal. This prompted us to
determine the cytotoxic lesion(s) induced by the topoisomerase-linked DNA
breaks. We have found that the topoisomerase I-DNA complexes induced by
camptothecin probably kill rapidly proliferative cells by interacting with
DNA replication complexes. We have also determined that
topoisomerase-mediated DNA breaks are not toxic in cells which have been
depleted of calcium. We have confirmed our previous finding that
pleiotropic resistant cell lines selected by exposure to adriamycin are
cross-resistant to other topoisomerase II inhibitors and have both
increased P-glycoprotein and modified topoisomerase II. In addition, we
have found that cells selected for resistance to vincristine have increased
P-glycoprotein without drug-resistant topoisomerase II. Finally, we found
evidence that two forms of DNA topoisomerase I are regulated by signal
transduction pathways including protein kinase C.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3916548
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
-
批准号:3939497
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA
-
批准号:3838171
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3752315
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3853153
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA AND RETROVIRAL INTEGRASES
-
批准号:2463724
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:2463710
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:3774547
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3752316
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3838030
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:2463709
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
STUDIES OF TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
-
批准号:3963209
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA STRAND BREAKS AS INDICATOR OF TOPOI
-
批准号:4692081
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
STUDIES OF TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
-
批准号:4692083
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA AND RETROVIRAL INTEGRASES
-
批准号:6100896
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3774548
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
-
批准号:6160983
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:3916549
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
-
批准号:5201240
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA
-
批准号:5201355
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Y POMMIER
-
依托单位:
海外基金